About Entero Therapeutics Inc. - Common Stock (ENTO)
Entero Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapies for gastrointestinal disorders and related health conditions. The company is dedicated to advancing its proprietary drug delivery technologies and treatment strategies that target the gastrointestinal tract, aiming to improve the lives of patients with challenging medical issues. Through rigorous research and development, Entero is committed to addressing unmet medical needs in the field of digestive health and enhancing the effectiveness of existing therapies. Read More
Transaction positions ENTO in the high-growth AI energy-infrastructure market, amid a surge of multi-billion-dollar hyperscaler spending on data centers, and rapid growth in behind-the-meter energy storage solutions
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Get a pulse on the US markets on Monday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.
The sub-$1 market is heating up with several high-profile moves in biotech, tech, and AI-driven media as investors chase high-volume breakouts and milestone-driven catalysts.
